Virax Biolabs COO, Dr Nigel McCracken, Discusses Immune Decoding with ViraxImmune™ on the MedTech Gurus Podcast

Nigel McCracken, Virax COO, Discusses the New Frontier in Immune Diagnostics with The Scientist in This Innovation Spotlight.

Virax COO, Nigel McCracken, Exaplains the Latest PAIS IVD Technolgy in His Latest PharmExec.com Interview.

In His Latest PharmExec.com Interview, Virax COO Nigel McCracken Shares New Insights Into the Link Between T Cell Exhaustion and Inflammation in Long-COVID.

Virax COO, Nigel McCracken, Discusses New Data on T Cell Exhaustion in Post-Acute Infection Syndromes with PharmExec.com in Latest Article.

Tune in now to listen to Dr. Nigel McCracken talk about “The Power of T Cell Immunology: Early Diagnosis, Immunotherapy, & the Future of Global Health” on the Finding Genius podcast

Join us for Inside Precision Medicine’s FREE State of Precision Medicine Summit on Wednesday, March 5th, 2025.

One of the key highlights is the “State of Molecular Diagnostics” panel at 2:30pm EST, featuring industry leaders including Virax Biolab’s COO, Dr Nigel McCracken, and moderated by North American Editor Jonathan D. Grinstein, PhD.

“Preparing for Potential Vaccine Regulatory Changes”: Virax CEO, James Foster, discusses how the industry is preparing for potential regulatory changes to vaccine policy

Article by Mike Hollan

Virax Biolabs Believes Technology Aligns with Unites States Department of Health and Human Services’ Transparency Priority on Vaccine Efficacy

“What Does 2025 Hold For Biopharma? Part 6: Therapeutic Area Advances”: Industry leaders including Virax CEO, James Foster, share their expectations for the year ahead

Article by Eleanor Malone